Clinical Trial Update: Lerapolturev (PVSRIPO) in GBM [Phase 2]

View source ↗

Summary

Lerapolturev (PVSRIPO) is being studied in a Phase 2 trial for recurrent supratentorial glioblastoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Lerapolturev (PVSRIPO) (PVSRIPO)

Snippet

Sponsor: Darell Bigner | Conditions: Recurrent Supratentorial Glioblastoma | Phase 2 | Status: RECRUITING